Brief: Anson Funds Management Delivers Letter To Chairman Of MEI Pharma
30/05/2023 22:23
May 30 (Reuters) - MEI Pharma Inc MEIP.O :
* ANSON FUNDS MANAGEMENT LP - ON MAY 23, DELIVERED LETTER TO
CHAIRMAN OF MEI PHARMA
* ANSON FUNDS MANAGEMENT - PROPOSAL TO ACQUIRE ALL SHARES OF
MEI
PHARMA FOR CASH CONSIDERATION OF NOT LESS THAN $8.00/SHARE, PLUS
CONTINGENT VALUE RIGHT
* ANSON FUNDS MANAGEMENT-BOUGHT SHARES OF MEI PHARMA ON
BELIEF
THAT SHARES,WHEN PURCHASED,WERE UNDERVALUED,REPRESENTED
ATTRACTIVE INVESTMENT OPPORTUNITY
* ANSON FUNDS MANAGEMENT LP REPORTS ABOUT 10% STAKE IN MEI
PHARMA
AS OF MAY 19 - SEC FILING
Source text for Eikon: ID:
Further company coverage: MEIP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations